Spectre SPAC Launches $60M IPO, Flags Major Conflicts of Interest

Ticker: SPEX · Form: S-1 · Filed: Dec 17, 2025 · CIK: 2099188

Spectre Acquisition Corp S-1 Filing Summary
FieldDetail
CompanySpectre Acquisition Corp (SPEX)
Form TypeS-1
Filed DateDec 17, 2025
Risk Levelhigh
Pages16
Reading Time19 min
Key Dollar Amounts$60,000,000, $0.033, $10.00, $0.0001, $11.50
Sentimentbearish

Sentiment: bearish

Topics: SPAC, IPO, Dilution, Conflicts of Interest, Blank Check Company, Cayman Islands, Nasdaq Listing

Related Tickers: SPEXU, SPEX, SPEXW

TL;DR

**Avoid SPEX; the insider-friendly structure and explicit conflicts of interest make this a high-risk gamble for public shareholders.**

AI Summary

Spectre Acquisition Corp (SPEX) is launching an initial public offering of 6,000,000 units at $10.00 per unit, aiming to raise $60,000,000. Each unit comprises one ordinary share and one redeemable warrant, with warrants exercisable at $11.50 per share. The company, a Cayman Islands-incorporated blank check company, has 18 to 21 months to complete a business combination, specifically excluding targets based in or with majority operations in the PRC. The sponsor purchased 1,725,000 insider shares for $25,000, or approximately $0.014 per share, and committed to buying 230,000 private units for $2,300,000. This low insider share price will result in immediate and substantial dilution for public shareholders. A significant portion of the proceeds, $60,000,000, will be held in a trust account managed by JP Morgan Chase & Co. and Efficiency INC. The filing highlights material conflicts of interest between the sponsor, officers, and directors and unaffiliated security holders, potentially influencing target selection and deal terms. Public shareholders face dilution and redemption limitations, with a maximum of 15% of shares redeemable without prior consent in certain scenarios.

Why It Matters

This S-1 filing reveals Spectre Acquisition Corp's intent to raise $60 million as a SPAC, but it's riddled with red flags for investors. The significant dilution from the sponsor's $0.014 per share purchase price, compared to the $10.00 public offering price, means public shareholders are immediately underwater. The explicit disclosure of 'material conflicts of interest' between insiders and public shareholders, particularly concerning target selection and deal terms, could lead to suboptimal acquisitions. This structure, common in SPACs, puts retail investors at a disadvantage, potentially impacting their returns and the broader market's perception of SPAC transparency and fairness.

Risk Assessment

Risk Level: high — The risk level is high due to the 'material conflicts of interest' explicitly stated between the sponsor, officers, and directors and unaffiliated security holders (page 29). The sponsor's purchase of 1,725,000 ordinary shares for $25,000 (approximately $0.014 per share) compared to the public offering price of $10.00 per unit creates immediate and substantial dilution for public shareholders (page 56). Additionally, redemption rights are limited to 15% of shares without prior consent in certain scenarios (page 28), further restricting shareholder protection.

Analyst Insight

Investors should exercise extreme caution and consider avoiding SPEX due to the significant dilution and explicit conflicts of interest. The low entry cost for insiders and the potential for them to prioritize their own financial gain over public shareholder returns suggest a poor risk-reward profile. If considering an investment, demand greater transparency and stronger shareholder protections before committing capital.

Financial Highlights

revenue
$0
operating Margin
N/A
total Assets
$60,000,000
total Debt
$0
net Income
$0
eps
$0.00
gross Margin
N/A
cash Position
$57,700,000
revenue Growth
N/A

Key Numbers

  • $60,000,000 — Gross proceeds from IPO (Amount to be raised from the initial public offering of 6,000,000 units.)
  • $10.00 — Offering price per unit (The price at which each unit, consisting of one ordinary share and one redeemable warrant, is offered to the public.)
  • 18 months — Time to complete business combination (Initial period for Spectre Acquisition Corp to effect a business combination, extendable up to 21 months.)
  • 1,725,000 — Insider shares purchased by sponsor (Number of ordinary shares purchased by the sponsor on November 20, 2025.)
  • $25,000 — Aggregate cost of insider shares (Total amount paid by the sponsor for 1,725,000 insider shares, equating to approximately $0.014 per share.)
  • $0.014 — Per share price for insider shares (The nominal price paid by the sponsor for their initial shares, highlighting significant dilution for public shareholders.)
  • $11.50 — Warrant exercise price (The price at which each warrant entitles the holder to purchase one ordinary share.)
  • $600,000 — Maximum loan repayment to sponsor (Aggregate amount of loans made by the sponsor to cover offering-related and organizational expenses.)
  • $10,000 — Monthly payment to sponsor (Amount paid monthly to the sponsor for office space, utilities, and administrative support until business combination or liquidation.)
  • 15% — Redemption rights limitation (Maximum percentage of shares a public shareholder can redeem without prior consent in connection with a business combination vote.)

Key Players & Entities

  • Spectre Acquisition Corp (company) — Registrant and blank check company
  • Lin Sun (person) — Agent for service
  • Mitchell Nussbaum, Esq. (person) — Counsel from Loeb & Loeb LLP
  • Alex Weniger-Araujo, Esq. (person) — Counsel from Loeb & Loeb LLP
  • Vivien Bai, Esq. (person) — Counsel from Loeb & Loeb LLP
  • Jason Osborn, Esq. (person) — Counsel from King & Spalding LLP
  • Allison Bell, Esq. (person) — Counsel from King & Spalding LLP
  • U.S. Securities and Exchange Commission (regulator) — Regulatory body for S-1 filing
  • JP Morgan Chase & Co. (company) — Trust account institution
  • Efficiency INC. (company) — Trust account trustee

FAQ

What is Spectre Acquisition Corp's primary business objective?

Spectre Acquisition Corp is a blank check company incorporated in the Cayman Islands with the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities.

How much capital is Spectre Acquisition Corp seeking to raise in its IPO?

Spectre Acquisition Corp is seeking to raise $60,000,000 through the initial public offering of 6,000,000 units at an offering price of $10.00 per unit.

What are the key components of each unit offered by Spectre Acquisition Corp?

Each unit offered by Spectre Acquisition Corp consists of one ordinary share with a par value of $0.0001 and one redeemable warrant. Each warrant entitles the holder to purchase one ordinary share at a price of $11.50 per share.

What is the deadline for Spectre Acquisition Corp to complete a business combination?

Spectre Acquisition Corp has 18 months from the closing of its initial public offering to complete a business combination, subject to extension up to 21 months by means of three one-month extensions, provided certain conditions are met.

What are the potential conflicts of interest highlighted in Spectre Acquisition Corp's S-1 filing?

The S-1 filing explicitly states 'material conflicts of interest' between the sponsor, officers, directors, and their affiliates, and unaffiliated security holders. These conflicts may influence the selection of a target business and the terms of a business combination, potentially leading to less favorable outcomes for public shareholders.

How much did Spectre Acquisition Corp's sponsor pay for their insider shares?

Spectre Acquisition Corp's sponsor purchased 1,725,000 ordinary shares for an aggregate of $25,000 on November 20, 2025, which equates to approximately $0.014 per share.

What is the impact of the sponsor's low purchase price on public shareholders of Spectre Acquisition Corp?

The nominal purchase price of approximately $0.014 per share paid by the sponsor for insider shares will result in immediate and substantial dilution to public shareholders upon the closing of the offering, assuming no value is ascribed to the warrants.

Where will the proceeds from Spectre Acquisition Corp's IPO be held?

Of the proceeds from the IPO and private unit sales, $60,000,000 will be deposited into a United States-based trust account established by JP Morgan Chase & Co. and maintained by Efficiency INC. as trustee.

Are there any geographic restrictions on Spectre Acquisition Corp's target business search?

Yes, Spectre Acquisition Corp will not pursue a prospective target company based in or having the majority of its operations in the People's Republic of China (PRC), which includes Hong Kong and Macau.

What are the limitations on redemption rights for Spectre Acquisition Corp's public shareholders?

Public shareholders are restricted from seeking redemption rights with respect to more than an aggregate of 15% of the shares sold in this offering without prior consent, in connection with any vote held to approve a proposed business combination.

Risk Factors

  • Dilution from Sponsor Shares [high — financial]: The sponsor purchased 1,725,000 ordinary shares for $25,000, or approximately $0.014 per share. This nominal price for insider shares will result in substantial dilution for public shareholders upon the completion of the business combination.
  • PRC Business Restrictions [medium — regulatory]: Spectre Acquisition Corp is prohibited from pursuing targets based in or with majority operations in the People's Republic of China (PRC). This restriction limits the pool of potential acquisition targets.
  • Limited Time for Business Combination [high — operational]: The company has an initial period of 18 months, extendable up to 21 months, to complete a business combination. Failure to do so will result in liquidation, posing a risk to investors.
  • Redemption Limitations [medium — financial]: Public shareholders face limitations on redemption rights, with a maximum of 15% of shares redeemable without prior consent in certain scenarios related to voting on a business combination. This can restrict shareholder liquidity.
  • Sponsor Loan Repayment [medium — financial]: The sponsor may be repaid up to $600,000 for loans covering offering-related and organizational expenses. This repayment reduces the capital available for the business combination.
  • Lack of Target Identification [high — operational]: Spectre Acquisition Corp has not identified any business combination target and has not initiated substantive discussions. This lack of a defined target increases uncertainty.
  • Conflicts of Interest [high — legal]: Material conflicts of interest exist between the sponsor, officers, and directors and unaffiliated security holders. These conflicts could influence target selection and deal terms, potentially disadvantaging public shareholders.

Industry Context

Spectre Acquisition Corp operates within the Special Purpose Acquisition Company (SPAC) sector. This market has seen significant growth, offering a pathway for private companies to go public. However, SPACs face intense competition for attractive acquisition targets and operate under strict timelines to complete a business combination before facing liquidation.

Regulatory Implications

As a Cayman Islands-incorporated entity, Spectre Acquisition Corp is subject to SEC regulations for its U.S. listing. The prohibition on targeting PRC-based companies highlights geopolitical considerations impacting SPACs. The structure of the offering, including redemption rights and sponsor compensation, is heavily scrutinized by regulators.

What Investors Should Do

  1. Analyze Sponsor Dilution
  2. Monitor Business Combination Progress
  3. Understand Redemption Rights and Limitations
  4. Evaluate Target Industry and Geography

Key Dates

  • 2025-11-20: Sponsor purchases insider shares — Highlights the significant discount at which the sponsor acquired initial shares, indicating potential for future dilution.
  • 2025-12-17: Filing of S-1 Registration Statement — Marks the initial public filing for the IPO, commencing the regulatory review process.

Glossary

Blank Check Company
A company formed with the sole purpose of raising capital through an initial public offering (IPO) to acquire an existing company, without having a specific target identified at the time of the IPO. (Spectre Acquisition Corp is a blank check company, meaning its primary goal is to find and merge with another business.)
Unit
A security offered in an IPO that typically consists of a share of common stock and a warrant to purchase additional shares. (SPEX is offering units, each containing one ordinary share and one redeemable warrant.)
Redeemable Warrant
A financial instrument that gives the holder the right, but not the obligation, to buy a stock at a specified price (exercise price) before its expiration date. (Holders of SPEX units receive warrants that can be exercised at $11.50 per share.)
Sponsor
The entity or individuals who form and finance a special purpose acquisition company (SPAC) or blank check company, typically receiving founder shares and warrants at a nominal cost. (The sponsor of SPEX purchased insider shares at a very low price, creating potential for dilution.)
Trust Account
An account established by a SPAC or blank check company to hold the proceeds from its IPO, which are typically invested in U.S. Treasury securities or money market funds, to be used for the business combination or returned to shareholders upon liquidation. (A significant portion of the $60,000,000 IPO proceeds will be held in a trust account.)
Insider Shares
Shares of a company purchased by its sponsor or founders at a nominal price before or during the IPO, often subject to transfer restrictions and vesting schedules. (SPEX's sponsor acquired 1,725,000 insider shares for $0.014 each, a key factor in potential dilution.)
Business Combination
The merger, acquisition, or other transaction through which a SPAC or blank check company combines with an operating company. (SPEX has 18-21 months to complete a business combination with a target company.)

Year-Over-Year Comparison

This is the initial S-1 filing for Spectre Acquisition Corp, therefore, there are no prior filings to compare financial metrics or risk factors against. Key details such as gross proceeds, offering price, sponsor share purchases, and the timeline for business combination are established in this document.

Filing Stats: 4,705 words · 19 min read · ~16 pages · Grade level 17.1 · Accepted 2025-12-17 14:01:27

Key Financial Figures

  • $60,000,000 — O COMPLETION, DATED December 17, 2025 $60,000,000 Spectre Acquisition Corp 6,000,000
  • $0.033 — hree one-month extensions provided that $0.033 per public share is deposited into the
  • $10.00 — ies. Each unit has an offering price of $10.00 and consists of one ordinary share of p
  • $0.0001 — s of one ordinary share of par value of $0.0001 (each an "ordinary share") and one rede
  • $11.50 — rchase one ordinary share at a price of $11.50 per share, subject to adjustment as des
  • $2,300,000 — vate unit for a total purchase price of $2,300,000 (or up to $2,435,000 if the underwriter
  • $2,435,000 — purchase price of $2,300,000 (or up to $2,435,000 if the underwriters' over-allotment opt
  • $600,000 — (i) repayment of an aggregate of up to $600,000 in loans made to us by our sponsor unde
  • $10,000 — ffering; (ii) payment to our sponsor of $10,000 per month from the closing of this offe
  • $3,000,000 — vate units upon the conversion of up to $3,000,000 of such loans at a price of $10.00 per
  • $0.014 — ued at a nominal price of approximately $0.014 per share, our public shareholders will
  • $69,000,000 — e of the private units, $60,000,000, or $69,000,000 if the underwriters' over-allotment opt
  • $50,000 — 7, 2025, ARC Group Limited has received $50,000 compensation in cash for its services a
  • $150,000 — its services and will receive a further $150,000 compensation in cash for its services u
  • $1,000 — its expenses in an amount not to exceed $1,000, and such cash compensation will not re

Filing Documents

From the Filing

As filed with the U.S. Securities and Exchange Commission on December 17, 2025. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Spectre Acquisition Corp (Exact name of registrant as specified in its charter) Cayman Islands 6770 N/A (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 1801 E Holt Blvd, #1162, Ontario, CA 91761 Telephone: +1 840 2129073 (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) Lin Sun 1801 E Holt Blvd, #1162, Ontario, CA 91761 Telephone: +1 840 2129073 (Name, address, including zip code, and telephone number, including area code, of agent for service) Copies to: Mitchell Nussbaum, Esq. Alex Weniger-Araujo, Esq. Vivien Bai, Esq. Loeb & Loeb LLP 345 Park Avenue New York, NY 10154 Tel: (212) 407-4000 Jason Osborn, Esq. Allison Bell, Esq. King & Spalding LLP 1290 Avenue of the Americas 14th Floor New York, NY 10104 Tel: (212) 556-2100 Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this registration statement. If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box. If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. Indicate by check mark whether the registrant is a large accelerated "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act. Large accelerated filer Accelerated filer Non-accelerated filer Smaller reporting company Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically as amended, or until the Registration Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine. The information in this preliminary prospectus is not complete and may be changed. We may not sell the securities being offered until the registration is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted. PRELIMINARY PROSPECTUS $60,000,000 Spectre Acquisition Corp 6,000,000 Units Spectre Acquisition Corp is a blank check company incorporated under the laws of the Cayman Islands as an exempted company with limited liability for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. We have 18 months from the closing of this initial public offering, subject to extension up to 21 months by means of three one-month extensions provided that $0.033 per public share is deposited into the trust account for each one-month extension and further provided that the Company has entered into an agreement for an initial business combination within that 18-month period. We have not selected any business combination target, and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. Our efforts to identify a prospective target business will not be limited to a particular industry or geographic region, except that we will not pursue a prospective target company based in or having the majority of its operations in the PRC. Throughout this prospectus, "PRC" refers to the People's Republic of China, including the Hong Kong Special Administrative Region and the Macau Special Administrative Region. This is an initial public offering of our securities. Each unit has an offe

View Full Filing

View this S-1 filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.